Resmed (RMD) Long-Term Deferred Tax (2010 - 2026)

Resmed's Long-Term Deferred Tax history runs 17 years deep, the most recent figure standing at $312.6 million for Q1 2026.

• Quarterly Long-Term Deferred Tax rose 44.19% year-over-year to $312.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $312.6 million (up 44.19% YoY) and the FY2025 annual result came in at $253.1 million, up 24.34% from the prior year.
• Long-Term Deferred Tax was $312.6 million for Q1 2026 at Resmed, up from $285.9 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $312.6 million in Q1 2026 and bottomed at $74.8 million in Q1 2022.
• A 5-year average of $175.5 million and a median of $162.1 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax dropped 0.2% — and 2023, when it surged 81.8%.
• Resmed's Long-Term Deferred Tax stood at $85.8 million in 2022, then soared by 81.8% to $156.0 million in 2023, then surged by 34.3% to $209.4 million in 2024, then soared by 36.51% to $285.9 million in 2025, then advanced by 9.33% to $312.6 million in 2026.
• Business Quant data shows RMD's Long-Term Deferred Tax at $312.6 million in Q1 2026, $285.9 million in Q4 2025, and $275.9 million in Q3 2025.